Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease

被引：0
|
作者：
Panagiotis Alexopoulos
Lukas Werle
Jennifer Roesler
Nathalie Thierjung
Lena Sophie Gleixner
Igor Yakushev
Nikolaos Laskaris
Stefan Wagenpfeil
Philippos Gourzis
Alexander Kurz
Robert Perneczky
机构：
[1] University Hospital of Rion,Department of Psychiatry
[2] University of Patras,Department of Psychiatry and Psychotherapy, Klinikum rechts der Isar
[3] Technische Universität München,Department of Nuclear Medicine, Klinikum rechts der Isar
[4] Max Planck Institute of Psychiatry,Department of Informatics
[5] Technische Universität München,Institute of Medical Biometrics, Epidemiology, and Medical Informatics (IMBEI)
[6] Aristotle University of Thessaloniki,Neuroepidemiology and Ageing Research Unit, School of Public Health, Faculty of Medicine
[7] University of the Saarland,Department of Psychiatry and Psychotherapy
[8] The Imperial College of Science,Department of Psychiatry
[9] Technology and Medicine,undefined
[10] Ludwig-Maximilans-Universität München,undefined
[11] University Hospital of Patras,undefined
[12] University of Patras,undefined
来源：
Alzheimer's Research & Therapy | / 8卷
关键词：
Prognosis; Alzheimer’s disease; Mild cognitive impairment; Cerebrospinal fluid;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer's disease
    Alexopoulos, Panagiotis
    Werle, Lukas
    Roesler, Jennifer
    Thierjung, Nathalie
    Gleixner, Lena Sophie
    Yakushev, Igor
    Laskaris, Nikolaos
    Wagenpfeil, Stefan
    Gourzis, Philippos
    Kurz, Alexander
    Perneczky, Robert
    ALZHEIMERS RESEARCH & THERAPY, 2016, 8
  • [2] Diagnostic and progression biomarkers in cerebrospinal fluid of Alzheimer’s disease patients
    Miyo K. Chatanaka
    Ioannis Prassas
    Eleftherios P. Diamandis
    BMC Medicine, 22
  • [3] Diagnostic and progression biomarkers in cerebrospinal fluid of Alzheimer's disease patients
    Chatanaka, Miyo K.
    Prassas, Ioannis
    Diamandis, Eleftherios P.
    BMC MEDICINE, 2024, 22 (01)
  • [4] Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's disease
    Sweeney, Melanie D.
    Sagare, Abhay P.
    Zlokovic, Berislav V.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2015, 35 (07): : 1055 - 1068
  • [5] Cerebrospinal Fluid Biomarkers in Familial Forms of Alzheimer's Disease and Frontotemporal Dementia
    Rostgaard, Nina
    Waldemar, Gunhild
    Nielsen, Jorgen Erik
    Simonsen, Anja Hviid
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2015, 40 (1-2) : 54 - 62
  • [6] Cerebrospinal fluid biomarkers of Alzheimer’s disease
    Xiaojing Sui
    Jianjun Liu
    Xifei Yang
    Neuroscience Bulletin, 2014, 30 : 233 - 242
  • [7] Cerebrospinal fluid biomarkers of Alzheimer's disease
    Fagan, Anne M.
    Holtzman, David M.
    BIOMARKERS IN MEDICINE, 2010, 4 (01) : 51 - 63
  • [8] Cerebrospinal fluid biomarkers in Alzheimer's disease
    Hugon, Jacques
    Dumurgier, Julien
    Cognat, Emmanuel
    Paquet, Claire
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2018, 202 (1-2): : 307 - 318
  • [9] Cerebrospinal fluid biomarkers of Alzheimer's disease
    Sui, Xiaojing
    Liu, Jianjun
    Yang, Xifei
    NEUROSCIENCE BULLETIN, 2014, 30 (02) : 233 - 242
  • [10] Cerebrospinal fluid biomarkers in Alzheimer's disease
    Lee, K. H.
    JOURNAL OF NEUROCHEMISTRY, 2013, 125 : 41 - 42
12345